Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis

NCT01602341 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: AN2728 Topical Ointment, 2% QD
DRUG: AN2728 Topical Ointment, 0.5% QD
DRUG: AN2728 Topical Ointment, 2% BID
DRUG: AN2728 Topical Ointment, 0.5% BID

Sponsor

Pfizer